Jasper Therapeutics Inc
JSPR
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.64M
Close$
$1.43
98.9% upside
Current Fair Value
98.9% upsideUndervalued by 98.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.64 Million |
|---|---|
| Enterprise Value | $4.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 3.03 |
| Outstanding Shares | 28,696,937 |
Return
| Return on Equity | -2165.39% |
|---|---|
| Return on Assets | -259.25% |
| Return on Invested Capital | -1231.16% |
Valuation & Multiples
| P/E Ratio | -0.45 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2236▲ 0.38% |
|---|---|
| Total Calls | 125,200▼ 22.04% |
| Total Puts | 28,000▼ 20.68% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.50%▼ 17.78% |
|---|---|
| Total Invested | $13.86M▼ 60.58% |
| Investors Holding | 60▲ 2.00% |
ESG Score
No data
About Jasper Therapeutics Inc
3 employees